//platform.linkedin.com/in.js

(Washington DC, May 23rd 2016): Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of hospitalizations in older adults, accounting for 726,000 hospitalizations and 1.5 million emergency department visits in the US in year 2000. Readmissions are a huge burden on healthcare resource utilization. Boston Strategic Partners, Inc. (BSP) researchers Dr. Fred Peyerl, Dr. Xuan Zhang, and David Hayashida conducted an EHR database study to explore the prevalence of COPD comorbidities and their impact on 30-day hospital readmission rates in recent years using Electronic Health Record (EHR) Data in order to gain insight on preventing COPD-related rehospitalizations.

The presentation will be on display at ISPOR today between 3.45pm to 7.45 pm. The poster author discussion hour is scheduled at 6.45pm to 7.45 pm. Visit the authors at booth 32 to learn more about the association between the prevalence of COPD comorbidities and readmission rates. The research is supported by detailed analyses of EHR database which contains information about 60 million unique patients over a 15 year timeframe. More information on this database can be found here.

Please check out our events section for the full list of presentation titles and timetable.

To schedule a meeting with our team, please email us at info@bostonsp.com. We look forward to discussing ideas and insights on health economics and outcomes research and ways to support your business and clinical needs.

About ISPOR

Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).

(Source: http://www.ispor.org/about-ispor.asp)